Citadel Advisors »

Viridian Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Viridian Therapeutics shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Viridian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viridian Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viridian Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $32M 30M 1.07